Cargando…

Quest for Biomarkers of Treatment-Resistant Depression: Shifting the Paradigm Toward Risk

The search for potential biomarkers of psychiatric disorders is a central topic in biological psychiatry. This review concerns published studies on potential biomarkers of treatment-resistant depression (TRD). The search for biomarkers of TRD in the bloodstream has focused on cytokines and steroids...

Descripción completa

Detalles Bibliográficos
Autor principal:	Smith, Donald F.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2013
Materias:	Psychiatry
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3684787/ https://www.ncbi.nlm.nih.gov/pubmed/23785338 http://dx.doi.org/10.3389/fpsyt.2013.00057

Ejemplares similares

ASD–Time for a paradigm shift
por: Levy, Yonata
Publicado: (2022)

Supported Decision-Making and Paradigm Shifts: Word Play or Real Change?
por: Stavert, Jill
Publicado: (2021)

Maximizing the Impact of e-Therapy and Serious Gaming: Time for a Paradigm Shift
por: Fleming, Theresa M., et al.
Publicado: (2016)

Biological correlates of treatment resistant depression: a review of peripheral biomarkers
por: Mancuso, Emiliana, et al.
Publicado: (2023)

A Brief Review of Paradigm Shifts in Prevention of Alzheimer’s Disease: From Cognitive Reserve to Precision Medicine
por: Hahn, Changtae, et al.
Publicado: (2019)

Corrigendum: A Brief Review of Paradigm Shifts in Prevention of Alzheimer's Disease: From Cognitive Reserve to Precision Medicine
por: Hahn, Changtae, et al.
Publicado: (2019)

Low Intensity Focused Ultrasound for Non-invasive and Reversible Deep Brain Neuromodulation—A Paradigm Shift in Psychiatric Research
por: Arulpragasam, Amanda R., et al.
Publicado: (2022)

Depression Reappraisal and Treatment Effect: Will Response Shift Help Improve the Estimation of Treatment Efficacy in Trials for Mood Disorders?
por: Bulteau, Samuel, et al.
Publicado: (2019)

Ketamine and Attentional Bias Toward Emotional Faces: Dynamic Causal Modeling of Magnetoencephalographic Connectivity in Treatment-Resistant Depression
por: Gilbert, Jessica R., et al.
Publicado: (2021)

Associations of Suicide Risk and Community Integration Among Patients With Treatment-Resistant Depression
por: Huong, Pham Thi Thu, et al.
Publicado: (2022)

Dextroamphetamine-Amphetamine Augmentation in the Treatment of Treatment-Resistant Depression
por: Small, Tyler M, et al.
Publicado: (2022)

Baseline Clinical and Neuroimaging Biomarkers of Treatment Response to High-Frequency rTMS Over the Left DLPFC for Resistant Depression
por: Harika-Germaneau, Ghina, et al.
Publicado: (2022)

Game Theory Paradigm: A New Tool for Investigating Social Dysfunction in Major Depressive Disorders
por: Wang, Yun, et al.
Publicado: (2015)

Optimizing Behavioral Paradigms to Facilitate Development of New Treatments for Anhedonia and Reward Processing Deficits in Schizophrenia and Major Depressive Disorder: Study Protocol
por: Bilderbeck, Amy C., et al.
Publicado: (2020)

Efficacy of Individualized Homeopathy in Treatment-Resistant Depression
por: Zepeda-Quiroz, Noheli, et al.
Publicado: (2021)

Editorial: Alternative treatments to classical antidepressants in treatment-resistant depression
por: Mikellides, Georgios, et al.
Publicado: (2023)

Cross-Validation of Paranoid-Depressive Scale and Functional MRI: New Paradigm for Neuroscience Informed Clinical Psychopathology
por: Stoyanov, Drozdstoy, et al.
Publicado: (2019)

Toward biophysical markers of depression vulnerability
por: Pinotsis, D. A., et al.
Publicado: (2022)

Hippocampal subfield volumes in treatment resistant depression and serial ketamine treatment
por: Zavaliangos-Petropulu, Artemis, et al.
Publicado: (2023)

Molecular Neurobiology of Depression: PET Findings on the Elusive Correlation with Symptom Severity
por: Smith, Donald F., et al.
Publicado: (2013)

Shift in the paradigm towards next-generation microbiology
por: Stres, Blaž, et al.
Publicado: (2019)

Treatment-Resistant Depression in Portugal: Perspective From Psychiatry Experts
por: Bessa, João M., et al.
Publicado: (2022)

The Quest for Meaning Around Self-Injurious and Suicidal Acts: A Qualitative Study Among Adolescent Girls
por: Grandclerc, Salomé, et al.
Publicado: (2019)

Treatment-Resistant Major Depression: Rationale for NMDA Receptors as Targets and Nitrous Oxide as Therapy
por: Zorumski, Charles F., et al.
Publicado: (2015)

Treatment-Resistant Depression in America Latina study: one-year follow-up of treatment resistant depression patients under standard of care reveals insights on quality of life, disability, work impairment, and depressive symptoms
por: Recco, Kelen, et al.
Publicado: (2023)

Novel paradigms for the gut–brain axis during alcohol withdrawal, withdrawal-associated depression, and craving in patients with alcohol use disorder
por: Vatsalya, Vatsalya, et al.
Publicado: (2023)

Potential Biomarkers for Predicting Depression in Diabetes Mellitus
por: Song, Xiuli, et al.
Publicado: (2021)

Identifying circulating biomarkers for major depressive disorder
por: Zhang, En, et al.
Publicado: (2023)

Cortisol Modulation by Ayahuasca in Patients With Treatment Resistant Depression and Healthy Controls
por: Galvão, Ana C. de Menezes, et al.
Publicado: (2018)

Repetitive Transcranial Magnetic Stimulation in Youth With Treatment Resistant Major Depression
por: MacMaster, Frank P., et al.
Publicado: (2019)

Antianhedonic Effect of Repeated Ketamine Infusions in Patients With Treatment Resistant Depression
por: Wilkowska, Alina, et al.
Publicado: (2021)

Economic evaluation of interventions for treatment-resistant depression: A systematic review
por: Hannah, Laura A., et al.
Publicado: (2023)

Commentary: Serum Biomarkers Are Potential Diagnosis and Treatment Targets for Depressive Symptoms in Patients With Cardiovascular Diseases
por: Liu, Cunming, et al.
Publicado: (2021)

Neuroinflammatory paradigms in lysosomal storage diseases
por: Bosch, Megan E., et al.
Publicado: (2015)

Decreased Resting-State Connectivity between Neurocognitive Networks in Treatment Resistant Depression
por: de Kwaasteniet, Bart P., et al.
Publicado: (2015)

Growth Factor Proteins and Treatment-Resistant Depression: A Place on the Path to Precision
por: Pisoni, Alice, et al.
Publicado: (2018)

Neural and Behavioral Correlates of Clinical Improvement to Ketamine in Adolescents With Treatment Resistant Depression
por: Thai, Michelle, et al.
Publicado: (2020)

Case Report: Lateral Habenula Deep Brain Stimulation for Treatment-Resistant Depression
por: Wang, Zhiyan, et al.
Publicado: (2021)

Risk Factors Linked to Depression After Treatment in Cancer Survivors in Jeddah, Saudi Arabia
por: Hajjay, Adel, et al.
Publicado: (2021)

Dexmedetomidine: Toward a paradigm shift in ICU sedation
por: Myatra, SN
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_llm2gcaf47cn7u53qlvb8bqhoi